Proteomics Studies Suggest That Nitric Oxide Donor Furoxans Inhibit In Vitro Vascular Smooth Muscle Cell Proliferation by Nitric Oxide-Independent Mechanisms

Physiologically, smooth muscle cells (SMC) and nitric oxide (NO) produced by endothelial cells strictly cooperate to maintain vasal homeostasis. In atherosclerosis, where this equilibrium is altered, molecules providing exogenous NO and able to inhibit SMC proliferation may represent valuable antiatherosclerotic agents. Searching for dual antiproliferative and NO-donor molecules, we found that furoxans significantly decreased SMC proliferation in vitro, albeit with different potencies. We therefore assessed whether this property is dependent on their thiol-induced ring opening. Indeed, while furazans (analogues unable to release NO) are not effective, furoxans’ inhibitory potency parallels with the electron-attractor capacity of the group in 3 of the ring, making this effect tunable. To demonstrate whether their specific block on G1-S phase could be NO-dependent, we supplemented SMCs with furoxans and inhibitors of GMP- and/or of the polyamine pathway, which regulate NO-induced SMC proliferation, but they failed in preventing the antiproliferative effect. To find the real mechanism of this property, our proteomics studies revealed that eleven cellular proteins (with SUMO1 being central) and networks involved in cell homeostasis/proliferation are modulated by furoxans, probably by interaction with adducts generated after degradation. Altogether, thanks to their dual effect and pharmacological flexibility, furoxans may be evaluated in the future as antiatherosclerotic molecules.

[1]  R. Matsubara,et al.  Recent progress in synthesis and application of furoxan , 2023, RSC advances.

[2]  P. Piomboni,et al.  Neurodegenerative Disorder Risk in Krabbe Disease Carriers , 2022, International journal of molecular sciences.

[3]  L. Bini,et al.  Untangling the Extracellular Matrix of Idiopathic Epiretinal Membrane: A Path Winding among Structure, Interactomics and Translational Medicine , 2022, Cells.

[4]  G. Francis,et al.  Smooth Muscle Cell—Macrophage Interactions Leading to Foam Cell Formation in Atherosclerosis: Location, Location, Location , 2022, Frontiers in Physiology.

[5]  M. Bros,et al.  The Role of KH-Type Splicing Regulatory Protein (KSRP) for Immune Functions and Tumorigenesis , 2022, Cells.

[6]  J. Björkegren,et al.  Atherosclerosis: Recent developments , 2022, Cell.

[7]  Ying Qin,et al.  Emerging Roles and Mechanism of m6A Methylation in Cardiometabolic Diseases , 2022, Cells.

[8]  K. Aquilano,et al.  MicroRNAs, Long Non-Coding RNAs, and Circular RNAs in the Redox Control of Cell Senescence , 2022, Antioxidants.

[9]  T. Long,et al.  Emerging role of m6A modification in cardiovascular diseases , 2022, Cell biology international.

[10]  B. Spengler,et al.  Drug Repurposing and De Novo Drug Discovery of Protein Kinase Inhibitors as New Drugs against Schistosomiasis , 2022, Molecules.

[11]  K. Roux,et al.  Mechanisms of A-Type Lamin Targeting to Nuclear Ruptures Are Disrupted in LMNA- and BANF1-Associated Progerias , 2022, bioRxiv.

[12]  A. Orekhov,et al.  The Role of the VEGF Family in Atherosclerosis Development and Its Potential as Treatment Targets , 2022, International journal of molecular sciences.

[13]  L. Mao,et al.  An update on the phenotypic switching of vascular smooth muscle cells in the pathogenesis of atherosclerosis , 2021, Cellular and Molecular Life Sciences.

[14]  Zhanyi Lin,et al.  Vascular Smooth Muscle Cells Mechanosensitive Regulators and Vascular Remodeling , 2021, Journal of Vascular Research.

[15]  Songmi Kim,et al.  Whole-exome sequencing reveals rare genetic variations in ovarian granulosa cell tumor , 2021, Bosnian journal of basic medical sciences.

[16]  Qiang He,et al.  Aspirin relieves the calcification of aortic smooth muscle cells by enhancing the heat shock response , 2021, Pharmaceutical biology.

[17]  L. Khachigian Early Growth Response‐1, an Integrative Sensor in Cardiovascular and Inflammatory Disease , 2021, Journal of the American Heart Association.

[18]  Q. Xiao,et al.  The Combined Regulation of Long Non-coding RNA and RNA-Binding Proteins in Atherosclerosis , 2021, Frontiers in Cardiovascular Medicine.

[19]  A. Brazma,et al.  The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences , 2021, Nucleic Acids Res..

[20]  F. Gao,et al.  Identification and functional analysis of changes to the ox-LDL-induced microRNA-124-3p/DLX5 axis in vascular smooth muscle cells. , 2021, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[21]  T. M. de Queiroz,et al.  Nitric Oxide as a Central Molecule in Hypertension: Focus on the Vasorelaxant Activity of New Nitric Oxide Donors , 2021, Biology.

[22]  Bo Yu,et al.  Plaque Erosion: A Distinctive Pathological Mechanism of Acute Coronary Syndrome , 2021, Frontiers in Cardiovascular Medicine.

[23]  C. Bailly,et al.  Interaction of obtusilactone B and related butanolide lactones with the barrier-to-autointegration factor 1 (BAF1). A computational study , 2021, Current research in pharmacology and drug discovery.

[24]  Min Cheng,et al.  The Role of m6A Ribonucleic Acid Modification in the Occurrence of Atherosclerosis , 2021, Frontiers in Genetics.

[25]  M. Tiwari,et al.  Regulation of integrin and extracellular matrix genes by HNRNPL is necessary for epidermal renewal , 2021, PLoS biology.

[26]  Peng Huang,et al.  Interleukin-22: a potential therapeutic target in atherosclerosis , 2021, Molecular Medicine.

[27]  Hu Li,et al.  Senescent cells suppress innate smooth muscle cell repair functions in atherosclerosis , 2021, Nature Aging.

[28]  Wei Liu,et al.  FBXO16-mediated hnRNPL ubiquitination and degradation plays a tumor suppressor role in ovarian cancer , 2021, Cell Death & Disease.

[29]  Dafeng Yang,et al.  A Smooth Muscle Cell–Enriched Long Noncoding RNA Regulates Cell Plasticity and Atherosclerosis by Interacting With Serum Response Factor , 2021, Arteriosclerosis, thrombosis, and vascular biology.

[30]  Sisi Wu,et al.  Molecular Dysfunctions of Mitochondria-Associated Endoplasmic Reticulum Contacts in Atherosclerosis , 2021, Oxidative medicine and cellular longevity.

[31]  P. Libby,et al.  Targeting inflammation in atherosclerosis — from experimental insights to the clinic , 2021, Nature Reviews Drug Discovery.

[32]  S. Goswami,et al.  mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification. , 2021, Cardiovascular research.

[33]  Huige Li,et al.  Regulation of NOS expression in vascular diseases. , 2021, Frontiers in bioscience.

[34]  Elisabetta Marini,et al.  Tuning NO release of organelle-targeted furoxan derivatives and their cytotoxicity against lung cancer cells. , 2021, Bioorganic chemistry.

[35]  P. Libby The changing landscape of atherosclerosis , 2021, Nature.

[36]  Lei Zheng,et al.  LncRNA AC105942.1 Downregulates hnRNPA2/B1 to Attenuate Vascular Smooth Muscle Cells Proliferation. , 2021, DNA and Cell Biology.

[37]  M. Banach,et al.  Foam Cells as Therapeutic Targets in Atherosclerosis with a Focus on the Regulatory Roles of Non-Coding RNAs , 2021, International journal of molecular sciences.

[38]  J. Sánchez-Alcázar,et al.  From Mitochondria to Atherosclerosis: The Inflammation Path , 2021, Biomedicines.

[39]  C. Cheong,et al.  Barrier-to-autointegration-factor (Banf1) modulates DNA double-strand break repair pathway choice via regulation of DNA-dependent kinase (DNA-PK) activity , 2021, Nucleic acids research.

[40]  A. Orekhov,et al.  Disturbance of Mitochondrial Dynamics and Mitochondrial Therapies in Atherosclerosis , 2021, Life.

[41]  C. Napoli,et al.  Novel Insights Regarding Nitric Oxide and Cardiovascular Diseases , 2021, Angiology.

[42]  Li‐Li Li,et al.  Advanced nitric oxide donors: chemical structure of NO drugs, NO nanomedicines and biomedical applications. , 2021, Nanoscale.

[43]  Jean-Charles Sanchez,et al.  Intracellular and Extracellular Markers of Lethality in Osteogenesis Imperfecta: A Quantitative Proteomic Approach , 2021, International journal of molecular sciences.

[44]  Laura S. Shankman,et al.  Multiple cell types contribute to the atherosclerotic lesion fibrous cap by PDGFRβ and bioenergetic mechanisms , 2020, Nature Metabolism.

[45]  M. Bennett,et al.  SIRT6 Protects Smooth Muscle Cells From Senescence and Reduces Atherosclerosis , 2020, Circulation research.

[46]  Byul A. Jee,et al.  Global spliceosome activity regulates entry into cellular senescence , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[47]  Yuhua Liao,et al.  Targeting IL-1β in the Treatment of Atherosclerosis , 2020, Frontiers in Immunology.

[48]  Haitao Wang,et al.  IRF-1 contributes to the pathological phenotype of VSMCs during atherogenesis by increasing CCL19 transcription , 2020, Aging.

[49]  N. Frey,et al.  SUMO proteins in the cardiovascular system: friend or foe? , 2020, Journal of biomedical science.

[50]  E. Yeh,et al.  SUMO: From Bench to Bedside. , 2020, Physiological reviews.

[51]  Mingyao Li,et al.  Single-Cell Genomics Reveals a Novel Cell State During Smooth Muscle Cell Phenotypic Switching and Potential Therapeutic Targets for Atherosclerosis in Mouse and Human , 2020, Circulation.

[52]  Peijun Liu,et al.  The function of SEC22B and its role in human diseases , 2020, Cytoskeleton.

[53]  Corey M. Williams,et al.  Stem Cell Pluripotency Genes Klf4 and Oct4 Regulate Complex SMC Phenotypic Changes Critical in Late-Stage Atherosclerotic Lesion Pathogenesis , 2020, Circulation.

[54]  C. Capanni,et al.  Emerin Phosphorylation during the Early Phase of the Oxidative Stress Response Influences Emerin–BAF Interaction and BAF Nuclear Localization , 2020, Cells.

[55]  Hongchun Liu,et al.  Downregulation of VRK1 reduces the expression of BANF1 and suppresses the proliferative and migratory activity of esophageal cancer cells , 2020, Oncology letters.

[56]  Shunlin Qu,et al.  SUMOylation in atherosclerosis. , 2020, Clinica chimica acta; international journal of clinical chemistry.

[57]  Qianjun He,et al.  Strategies for engineering advanced nanomedicines for gas therapy of cancer , 2020, National science review.

[58]  R. Krauss,et al.  Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel , 2020, European heart journal.

[59]  M. Zheng,et al.  Inhibition of KHSRP sensitizes colorectal cancer to 5‐fluoruracil through miR‐501‐5p‐mediated ERRFI1 mRNA degradation , 2020, Journal of cellular physiology.

[60]  Galen P. Miley,et al.  Inducible nitric oxide synthase: Regulation, structure, and inhibition , 2020, Medicinal research reviews.

[61]  Neha S. Gandhi,et al.  Barrier-to-autointegration factor 1 (Banf1) regulates poly [ADP-ribose] polymerase 1 (PARP1) activity following oxidative DNA damage , 2019, Nature Communications.

[62]  Jiusheng Deng,et al.  Silencing of long non-coding RNA H19 downregulates CTCF to protect against atherosclerosis by upregulating PKD1 expression in ApoE knockout mice , 2019, Aging.

[63]  D. Branzei,et al.  SUMO-Chain-Regulated Proteasomal Degradation Timing Exemplified in DNA Replication Initiation , 2019, Molecular cell.

[64]  M. Banach,et al.  The Role of Protein SUMOylation in the Pathogenesis of Atherosclerosis , 2019, Journal of clinical medicine.

[65]  S. Hattori,et al.  C9-ALS/FTD-linked proline–arginine dipeptide repeat protein associates with paraspeckle components and increases paraspeckle formation , 2019, Cell Death & Disease.

[66]  P. Gresele,et al.  Nitric oxide-enhancing or -releasing agents as antithrombotic drugs. , 2019, Biochemical pharmacology.

[67]  Huili Wang,et al.  MicroRNA-591 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Lowering Drug Resistance through Inhibition of Far-Upstream Element-Binding Protein 2-Mediated Phosphoinositide 3-Kinase/Akt/Mammalian Target of Rapamycin Axis , 2019, Pharmacology.

[68]  N. Yusuf,et al.  KSRP modulates melanoma growth and efficacy of vemurafenib. , 2019, Biochimica et biophysica acta. Gene regulatory mechanisms.

[69]  M. Bennett,et al.  Vascular smooth muscle cells in atherosclerosis , 2019, Nature Reviews Cardiology.

[70]  J. New,et al.  Autophagy-dependent secretion: mechanism, factors secreted, and disease implications , 2019, Autophagy.

[71]  Isaac T. Schiefer,et al.  Pharmacokinetics and pharmacodynamics of nitric oxide mimetic agents. , 2019, Nitric oxide : biology and chemistry.

[72]  Bo Tang,et al.  SUMOylation of Vps34 by SUMO1 promotes phenotypic switching of vascular smooth muscle cells by activating autophagy in pulmonary arterial hypertension. , 2019, Pulmonary pharmacology & therapeutics.

[73]  P. Sun,et al.  MicroRNA profiling of diabetic atherosclerosis in a rat model , 2018, European Journal of Medical Research.

[74]  A. Atanasov,et al.  Vascular smooth muscle cell proliferation as a therapeutic target. Part 1: molecular targets and pathways. , 2018, Biotechnology advances.

[75]  V. Deretic,et al.  Role of autophagy in IL-1β export and release from cells. , 2018, Seminars in cell & developmental biology.

[76]  Feng Xu,et al.  Transactive response DNA binding protein of 43/histone deacetylase 6 axis alleviates H 2O 2‐induced retinal ganglion cells injury through inhibiting apoptosis and autophagy , 2018, Journal of cellular biochemistry.

[77]  Xiaoling Liu,et al.  MicroRNA-124-3p inhibits collagen synthesis in atherosclerotic plaques by targeting prolyl 4-hydroxylase subunit alpha-1 (P4HA1) in vascular smooth muscle cells. , 2018, Atherosclerosis.

[78]  J. Tardif,et al.  Examining the Role of and Treatment Directed at IL-1β in Atherosclerosis , 2018, Current Atherosclerosis Reports.

[79]  Yunlong Liu,et al.  Long noncoding RNA NEAT1 (nuclear paraspeckle assembly transcript 1) is critical for phenotypic switching of vascular smooth muscle cells , 2018, Proceedings of the National Academy of Sciences.

[80]  R. Strasser,et al.  Sox9 is increased in arterial plaque and stenosis, associated with synthetic phenotype of vascular smooth muscle cells and causes alterations in extracellular matrix and calcification. , 2018, Biochimica et biophysica acta. Molecular basis of disease.

[81]  Wenchen Pu,et al.  Long Noncoding RNA AB074169 Inhibits Cell Proliferation via Modulation of KHSRP-Mediated CDKN1a Expression in Papillary Thyroid Carcinoma. , 2018, Cancer research.

[82]  N. Cairns,et al.  TDP-43 interacts with mitochondrial proteins critical for mitophagy and mitochondrial dynamics , 2018, Neuroscience Letters.

[83]  S. Allahverdian,et al.  Smooth muscle cell fate and plasticity in atherosclerosis , 2018, Cardiovascular research.

[84]  Viorel Simion,et al.  Long Non-Coding RNAs in Vascular Inflammation , 2018, Front. Cardiovasc. Med..

[85]  Viorel Simion,et al.  LncRNAs in vascular biology and disease. , 2018, Vascular pharmacology.

[86]  M. Bootman,et al.  Calcium phosphate particles stimulate interleukin-1β release from human vascular smooth muscle cells: A role for spleen tyrosine kinase and exosome release , 2018, Journal of molecular and cellular cardiology.

[87]  C. Boosani,et al.  Role of Transcription Factors in Regulating Development and Progression of Atherosclerosis , 2018 .

[88]  Jason L Johnson,et al.  Metalloproteinases in atherosclerosis , 2017, European journal of pharmacology.

[89]  Xinghui Sun,et al.  The role of interactions of long non-coding RNAs and heterogeneous nuclear ribonucleoproteins in regulating cellular functions , 2017, The Biochemical journal.

[90]  M. Hasegawa,et al.  TDP-43 stabilises the processing intermediates of mitochondrial transcripts , 2017, Scientific Reports.

[91]  A. Burilov,et al.  Novel Structural Hybrids on the Base of Benzofuroxans and Furoxans. Mini-Review. , 2017, Current topics in medicinal chemistry.

[92]  E. Masini,et al.  New furoxan derivatives for the treatment of ocular hypertension. , 2017, Bioorganic & medicinal chemistry letters.

[93]  M. Liang,et al.  Heterogeneous nuclear ribonucleoprotein M associates with mTORC2 and regulates muscle differentiation , 2017, Scientific Reports.

[94]  K. Lidke,et al.  Dedicated SNAREs and specialized TRIM cargo receptors mediate secretory autophagy , 2017, The EMBO journal.

[95]  Ning Wang,et al.  Transcription upregulation via force-induced direct stretching of chromatin , 2016, Nature materials.

[96]  Hu Li,et al.  The Inhibition of TDP-43 Mitochondrial Localization Blocks Its Neuronal Toxicity , 2016, Nature Medicine.

[97]  C. Landi,et al.  Protein pathways working in human follicular fluid: the future for tailored IVF? , 2016, Expert Reviews in Molecular Medicine.

[98]  G. Francis,et al.  So Much Cholesterol: the unrecognized importance of smooth muscle cells in atherosclerotic foam cell formation , 2016, Current opinion in lipidology.

[99]  Guo-liang Zhang,et al.  SUMOylation of KLF4 acts as a switch in transcriptional programs that control VSMC proliferation. , 2016, Experimental cell research.

[100]  G. Garcı́a-Cardeña,et al.  Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. , 2016, Circulation research.

[101]  M. Bennett,et al.  Vascular Smooth Muscle Cells in Atherosclerosis. , 2016, Circulation research.

[102]  C. López-Otín,et al.  Barrier-to-Autointegration Factor (BAF) involvement in prelamin A-related chromatin organization changes , 2015, Oncotarget.

[103]  Gregory J. Crowther,et al.  High-throughput screening against thioredoxin glutathione reductase identifies novel inhibitors with potential therapeutic value for schistosomiasis , 2015, Infectious Diseases of Poverty.

[104]  A. Vertegaal,et al.  SUMO in the DNA damage response , 2015, Oncotarget.

[105]  M. Wiebe,et al.  Barrier to Autointegration Factor (BANF1): interwoven roles in nuclear structure, genome integrity, innate immunity, stress responses and progeria. , 2015, Current opinion in cell biology.

[106]  C. Dieterich,et al.  Label-Free Protein-RNA Interactome Analysis Identifies Khsrp Signaling Downstream of the p38/Mk2 Kinase Complex as a Critical Modulator of Cell Cycle Progression , 2015, PloS one.

[107]  Laura S. Shankman,et al.  KLF4 Dependent Phenotypic Modulation of SMCs Plays a Key Role in Atherosclerotic Plaque Pathogenesis , 2015, Nature Medicine.

[108]  Toru Suzuki,et al.  miR-200c-SUMOylated KLF4 feedback loop acts as a switch in transcriptional programs that control VSMC proliferation. , 2015, Journal of molecular and cellular cardiology.

[109]  C. Bogdan Nitric oxide synthase in innate and adaptive immunity: an update. , 2015, Trends in immunology.

[110]  K. Bornfeldt,et al.  Arterial smooth muscle. , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[111]  R. Feil,et al.  Transdifferentiation of Vascular Smooth Muscle Cells to Macrophage-Like Cells During Atherogenesis , 2014, Circulation research.

[112]  E. Patsouris,et al.  NF-κB signaling at the crossroads of inflammation and atherogenesis: searching for new therapeutic links , 2014, Expert opinion on therapeutic targets.

[113]  Dongsik Park,et al.  A platform for nitric oxide delivery. , 2014, Journal of materials chemistry. B.

[114]  Zhonghan Li,et al.  The long noncoding RNA THRIL regulates TNFα expression through its interaction with hnRNPL , 2013, Proceedings of the National Academy of Sciences.

[115]  Jürgen Cox,et al.  1D and 2D annotation enrichment: a statistical method integrating quantitative proteomics with complementary high-throughput data , 2012, BMC Bioinformatics.

[116]  C. López-Otín,et al.  Néstor–Guillermo progeria syndrome: A novel premature aging condition with early onset and chronic development caused by BANF1 mutations , 2011, American journal of medical genetics. Part A.

[117]  R. A. Forse,et al.  Carcinoembryonic antigen (CEA) and its receptor hnRNP M are mediators of metastasis and the inflammatory response in the liver , 2011, Clinical & Experimental Metastasis.

[118]  J. Bujnicki,et al.  STAT1 as a novel therapeutical target in pro-atherogenic signal integration of IFNγ, TLR4 and IL-6 in vascular disease. , 2011, Cytokine & growth factor reviews.

[119]  V. Quesada,et al.  Exome sequencing and functional analysis identifies BANF1 mutation as the cause of a hereditary progeroid syndrome. , 2011, American journal of human genetics.

[120]  Nick D. Tsihlis,et al.  Nitric Oxide Inhibits Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia by Increasing the Ubiquitination and Degradation of UbcH10 , 2011, Cell Biochemistry and Biophysics.

[121]  M. Mann,et al.  Andromeda: a peptide search engine integrated into the MaxQuant environment. , 2011, Journal of proteome research.

[122]  H. Shimokawa,et al.  Pathophysiological relevance of NO signaling in the cardiovascular system: novel insight from mice lacking all NO synthases. , 2010, Pharmacology & therapeutics.

[123]  Y. Mandel-Gutfreund,et al.  Heterogeneous Nuclear Ribonucleoprotein H1/H2-dependent Unsplicing of Thymidine Phosphorylase Results in Anticancer Drug Resistance , 2010, The Journal of Biological Chemistry.

[124]  B. Blencowe,et al.  The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. , 2010, Molecular cell.

[125]  A. Ramos,et al.  The role of KSRP in mRNA decay and microRNA precursor maturation , 2010, Wiley interdisciplinary reviews. RNA.

[126]  L. Lazzarato,et al.  Synthesis of some novel organic nitrates and comparative in vitro study of their vasodilator profile. , 2009, Journal of medicinal chemistry.

[127]  J. Stone,et al.  Up-regulation of a hydrogen peroxide-responsive pre-mRNA binding protein in atherosclerosis and intimal hyperplasia. , 2009, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[128]  M. Mann,et al.  Universal sample preparation method for proteome analysis , 2009, Nature Methods.

[129]  M. Hatzoglou,et al.  A stress-responsive RNA switch regulates VEGF expression , 2008, Nature.

[130]  C. Harris,et al.  The chemical biology of nitric oxide: implications in cellular signaling. , 2008, Free radical biology & medicine.

[131]  Anton Simeonov,et al.  Identification of oxadiazoles as new drug leads for the control of schistosomiasis , 2008, Nature Medicine.

[132]  Y. Hiraoka,et al.  Nuclear localization of barrier-to-autointegration factor is correlated with progression of S phase in human cells , 2007, Journal of Cell Science.

[133]  M. Runge,et al.  Mitochondrial Dysfunction in Atherosclerosis , 2007, Circulation research.

[134]  Matthias Mann,et al.  Innovations: Functional and quantitative proteomics using SILAC , 2006, Nature Reviews Molecular Cell Biology.

[135]  P. Weissberg,et al.  Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification , 2006, Journal of internal medicine.

[136]  T. Littlewood,et al.  Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis , 2006, Nature Medicine.

[137]  V. Steele,et al.  Nitric oxide–releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets , 2006, Molecular Cancer Therapeutics.

[138]  M. Aldea,et al.  1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. , 2006, Kidney international.

[139]  T. Littlewood,et al.  Cell death in the cardiovascular system , 2006, Heart.

[140]  K. Naseem The role of nitric oxide in cardiovascular diseases. , 2005, Molecular aspects of medicine.

[141]  F. Callea,et al.  Co-expression and modulation of neuronal and endothelial nitric oxide synthase in human endothelial cells. , 2004, Journal of molecular and cellular cardiology.

[142]  M. Karin,et al.  A KH domain RNA binding protein, KSRP, promotes ARE-directed mRNA turnover by recruiting the degradation machinery. , 2004, Molecular cell.

[143]  Uichi Ikeda,et al.  Matrix metalloproteinases and atherosclerosis , 2004, Current atherosclerosis reports.

[144]  J. Loscalzo,et al.  Nitric oxide in vascular biology , 2003, Journal of thrombosis and haemostasis : JTH.

[145]  Merlin Crossley,et al.  Modification with SUMO , 2003, EMBO reports.

[146]  Y. Sasaguri,et al.  Vasculoprotective Roles of Neuronal Nitric Oxide Synthase , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[147]  Ruediger C. Braun-Dullaeus,et al.  Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies , 2002, Nature Medicine.

[148]  M. Bennett,et al.  Human Macrophage-Induced Vascular Smooth Muscle Cell Apoptosis Requires NO Enhancement of Fas/Fas-L Interactions , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[149]  Ming Xian,et al.  Nitric oxide donors: chemical activities and biological applications. , 2002, Chemical reviews.

[150]  M. Gelb,et al.  Effect of S(-) perillic acid on protein prenylation and arterial smooth muscle cell proliferation. , 2001, Biochemical pharmacology.

[151]  J. Fox,et al.  Mice lacking inducible nitric oxide synthase develop spontaneous hypercholesterolaemia and aortic atheromas. , 2001, Atherosclerosis.

[152]  M. Bonini,et al.  Carbon Dioxide Stimulates the Production of Thiyl, Sulfinyl, and Disulfide Radical Anion from Thiol Oxidation by Peroxynitrite* , 2001, The Journal of Biological Chemistry.

[153]  L. Ignarro,et al.  Inaugural Article: Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation , 2001 .

[154]  Christopher K. Glass,et al.  Atherosclerosis The Road Ahead , 2001, Cell.

[155]  E. Raines,et al.  The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease , 2000, International journal of experimental pathology.

[156]  G. Kojda,et al.  Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. , 2000, The Journal of clinical investigation.

[157]  R. Virmani,et al.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[158]  E. Nabel,et al.  Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. , 2000, Circulation.

[159]  G. Neubauer,et al.  Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Iβ , 2000, Nature.

[160]  J. Cooke,et al.  Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[161]  J. Pollock,et al.  Functional expression of NOS 1 in vascular smooth muscle. , 2000, American journal of physiology. Heart and circulatory physiology.

[162]  B. Zetter,et al.  Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. , 1999, Microvascular research.

[163]  H. Wellens,et al.  Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques. , 1999, Cardiovascular research.

[164]  B. Lévy,et al.  Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells: activation by angiotensin II in hypertension. , 1998, Circulation research.

[165]  W. Koppenol,et al.  The basic chemistry of nitrogen monoxide and peroxynitrite. , 1998, Free radical biology & medicine.

[166]  Xing-li Wang,et al.  Nitric oxide induces and inhibits apoptosis through different pathways , 1998, FEBS letters.

[167]  P. Klatt,et al.  Defective smooth muscle regulation in cGMP kinase I‐deficient mice , 1998, The EMBO journal.

[168]  K. Walsh,et al.  Nitric oxide-induced downregulation of Cdk2 activity and cyclin A gene transcription in vascular smooth muscle cells. , 1998, Circulation.

[169]  M. Gelb,et al.  Pharmacological control of the mevalonate pathway: effect on arterial smooth muscle cell proliferation. , 1997, The Journal of pharmacology and experimental therapeutics.

[170]  H. Granger,et al.  Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. , 1997, Circulation research.

[171]  H. Nojima,et al.  Induction of the Cyclin-dependent Kinase Inhibitor p21Sdi1/Cip1/Waf1 by Nitric Oxide-generating Vasodilator in Vascular Smooth Muscle Cells* , 1997, The Journal of Biological Chemistry.

[172]  K. Morgan,et al.  Mechanisms of smooth muscle contraction. , 1996, Physiological reviews.

[173]  M. Yacoub,et al.  Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[174]  H. Drexler,et al.  Role of endogenous bradykinin in human coronary vasomotor control. , 1995, Circulation.

[175]  J. Keaney,et al.  Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action. , 1995, Progress in cardiovascular diseases.

[176]  P. Libby,et al.  Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. , 1995, The American journal of pathology.

[177]  K. Williams,et al.  The response-to-retention hypothesis of early atherogenesis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[178]  G. Evan,et al.  Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. , 1995, The Journal of clinical investigation.

[179]  P. Martorana,et al.  Cardiovascular actions of the furoxan CAS 1609, a novel nitric oxide donor , 1995, British journal of pharmacology.

[180]  W E Haefeli,et al.  Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. , 1995, Circulation.

[181]  R. Fruttero,et al.  A new class of furoxan derivatives as NO donors: mechanism of action and biological activity , 1995, British journal of pharmacology.

[182]  R. Fruttero,et al.  Furoxans as nitric oxide donors. 4-Phenyl-3-furoxancarbonitrile: thiol-mediated nitric oxide release and biological evaluation. , 1994, Journal of medicinal chemistry.

[183]  E. Arnold,et al.  Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. , 1994, The American journal of physiology.

[184]  U. Walter,et al.  Regulation of calcium mobilization and entry in human platelets by endothelium-derived factors. , 1994, The American journal of physiology.

[185]  R. Cohen,et al.  Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle , 1994, Nature.

[186]  G. Evan,et al.  Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. , 1994, The Journal of clinical investigation.

[187]  R. Alexander,et al.  Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. , 1993, The Journal of clinical investigation.

[188]  R. Fruttero,et al.  No-mimetic furoxans: arylsulphonylfuroxans and related compounds. , 1993, Pharmacological research.

[189]  J. Stamler,et al.  Biochemistry of nitric oxide and its redox-activated forms. , 1992, Science.

[190]  M. Feelisch,et al.  Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans. , 1992, Biochemical pharmacology.

[191]  J. Eaton,et al.  Ferritin: a cytoprotective antioxidant strategem of endothelium. , 1992, The Journal of biological chemistry.

[192]  J. Hevel,et al.  Purification of the inducible murine macrophage nitric oxide synthase. Identification as a flavoprotein. , 1991, The Journal of biological chemistry.

[193]  B. Freeman,et al.  Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. , 1991, Archives of biochemistry and biophysics.

[194]  Julie H. Campbell,et al.  Arterial smooth muscle. A multifunctional mesenchymal cell. , 1988, Archives of pathology & laboratory medicine.

[195]  Zong-Lai Jiang,et al.  Mechanobiology and Vascular Remodeling: From Membrane to Nucleus. , 2018, Advances in experimental medicine and biology.

[196]  R. Khalil,et al.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease. , 2018, Advances in pharmacology.

[197]  H. Gaod,et al.  Long noncoding RNA NEAT 1 ( nuclear paraspeckle assembly transcript 1 ) is critical for phenotypic switching of vascular smooth muscle cells , 2018 .

[198]  H. Duan,et al.  MiR-1243 p inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration through targeting STAT 3 , 2017 .

[199]  C. Baines,et al.  Cell biology of ischemia/reperfusion injury. , 2012, International review of cell and molecular biology.

[200]  C. Eyers Universal sample preparation method for proteome analysis , 2009 .

[201]  Nick D. Tsihlis,et al.  Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia. , 2008, Journal of vascular surgery.

[202]  L. Trümper From bench to bedside , 2005, Medizinische Klinik.

[203]  A. Faggiotto,et al.  Effect of the new HMG-CoA reductase inhibitor cerivastatin (BAY W 6228)on migration, proliferation and cholesterol synthesis in arterial myocytes. , 1996, Pharmacological research.